Description
ROSUEX-F contains Rosuvastatin I.P. 10 mg and Fenofibrate I.P. 160 mg in tablet form. This combination brings together two lipid-lowering medicines with complementary actions. Rosuvastatin primarily lowers LDL cholesterol, while Fenofibrate helps reduce triglycerides and can improve other lipid parameters. The combination may be prescribed for selected patients with mixed lipid abnormalities when combination therapy is considered appropriate.
For related cardiovascular and pharmaceutical formulations, explore the Medhexa Pharma product range for pharmaceutical products and business enquiries.
Therapeutic Segment
Cardiovascular Care | Lipid-Lowering Therapy | Statins | Fibrates | Cholesterol & Triglyceride Management
Uses of ROSUEX-F
ROSUEX-F may be prescribed as part of a lipid-management plan for selected patients with:
- Mixed dyslipidemia involving elevated cholesterol and triglycerides
- High LDL cholesterol requiring statin therapy
- Elevated triglyceride levels
- Primary hypercholesterolemia or mixed lipid abnormalities
- Patients requiring additional lipid-lowering treatment when a single medicine does not provide adequate control
Rosuvastatin reduces LDL cholesterol, while Fenofibrate primarily targets triglycerides and can improve other components of the lipid profile. The need for combination therapy depends on the patient’s lipid profile, cardiovascular risk, medical history and response to treatment.
Key Benefits of ROSUEX-F
- Dual lipid-lowering action: Combines a statin with a fibrate for complementary effects on blood lipids.
- Supports LDL cholesterol control: Rosuvastatin helps lower LDL cholesterol.
- Supports triglyceride management: Fenofibrate helps reduce elevated triglycerides.
- Helps improve lipid profile: The two medicines act through different pathways to address selected lipid abnormalities.
- 10 mg Rosuvastatin + 160 mg Fenofibrate: Provides a fixed combination in one oral tablet.
- Convenient oral formulation: Supports prescribed lipid-management regimens.
How ROSUEX-F Works
Rosuvastatin belongs to the statin class. It inhibits HMG-CoA reductase, an enzyme involved in cholesterol production in the liver. This reduces cholesterol synthesis and increases the liver’s uptake of LDL cholesterol from the bloodstream.
Fenofibrate activates PPAR-alpha, a receptor involved in lipid metabolism. This helps regulate the production and breakdown of lipoproteins and can reduce elevated triglycerides while improving other lipid parameters.
Therefore, ROSUEX-F combines two different mechanisms to address selected cholesterol and triglyceride abnormalities.
Common Side Effects of ROSUEX-F
Some people taking rosuvastatin or fenofibrate may experience:
- Headache
- Dizziness
- Nausea
- Indigestion
- Abdominal discomfort
- Constipation or diarrhoea
- Muscle aches
- Tiredness or weakness
Because the combination contains both a statin and a fibrate, muscle-related adverse effects require particular attention. Seek medical advice promptly if you develop unexplained or severe muscle pain, tenderness or weakness, especially if accompanied by fever or dark-coloured urine.
Important Safety Information
Use ROSUEX-F only according to the advice of a qualified healthcare professional.
- Inform your doctor if you have kidney disease, liver disease or a history of gallbladder disease.
- Fenofibrate is contraindicated in severe renal dysfunction, active liver disease and gallbladder disease according to its prescribing information.
- Report unexplained muscle pain, tenderness, cramps or weakness promptly. Combining a statin with a fibrate can increase concern for muscle toxicity.
- Seek urgent medical advice if severe muscle symptoms occur with weakness, fever or dark-coloured urine.
- Tell your doctor if you have an underactive thyroid or a previous history of muscle problems associated with cholesterol-lowering medicines.
- Liver function may require monitoring during treatment.
- Kidney function may also need monitoring, particularly because Fenofibrate dosing depends on renal function.
- Tell your healthcare professional about all medicines, vitamins and supplements you take.
- Rosuvastatin can interact with several medicines, including certain antiviral medicines, ciclosporin and some other lipid-lowering medicines.
- Fenofibrate can interact with anticoagulants such as warfarin and may require additional monitoring.
- Inform your doctor if you develop symptoms that could suggest gallbladder problems, such as persistent upper abdominal pain.
- Avoid excessive alcohol consumption because both medicines can be associated with liver-related concerns.
- Rosuvastatin is not recommended during pregnancy. Discuss pregnancy and breastfeeding with your healthcare professional before using this combination.
- Continue the recommended diet, exercise and other lifestyle measures alongside prescribed treatment.
For additional information about rosuvastatin, refer to the NHS rosuvastatin guidance.
Dosage & Administration
Take ROSUEX-F exactly as prescribed by your healthcare professional.
The appropriate treatment plan depends on the patient’s cholesterol and triglyceride levels, kidney and liver function, cardiovascular risk, other medicines and response to therapy.
Rosuvastatin is generally administered once daily and can be taken with or without food. Fenofibrate 160 mg products are commonly administered once daily, with the specific administration instructions depending on the formulation and approved product information.
Do not increase, reduce or discontinue the dose without medical advice. Regular lipid testing and appropriate clinical monitoring may be recommended during treatment.
Storage
- Store in a cool, dry place.
- Protect the tablets from excessive heat and moisture.
- Keep the tablets in their original packaging until use.
- Keep out of the sight and reach of children.
- Do not use after the expiry date printed on the pack.
